A high CMV-specific T cell response associates with SARS-CoV-2-specific IL-17 T cell production

Med Microbiol Immunol. 2023 Feb;212(1):75-91. doi: 10.1007/s00430-022-00758-1. Epub 2022 Dec 13.

Abstract

Human cytomegalovirus (CMV) is a widespread persistent herpes virus requiring lifelong immune surveillance to maintain latency. Such long-term interactions with the immune system may be associated with deleterious effects including immune exhaustion and senescence. Regarding the COVID-19 pandemic, we asked whether CMV-specific cellular and humoral activity could influence immune responses toward SARS-CoV-2 and/or disease severity. All adults with mild (n = 15) and severe (n = 14) COVID-19 were seropositive for anti-CMV IgG, but negative for IgM antibodies. Antibody titers did not correlate with COVID-19 severity. Six patients presented elevated frequencies of CMV-specific CD4 + and CD8 + T cells producing IFNγ, IL-17, and TNFα, designated as CMV high responders (hiT CMV). In comparison to low CMV responders, hiT CMV individuals exhibited higher frequencies of SARS-CoV-2-specific CD4 + IL-17 + and CD8 + IFNγ + , IL-17 + or TNFα + T cells. These results indicate that high frequencies of CMV-specific T cells may be associated with a SARS-CoV-2-reactive profile skewed toward Th17-dominated immunity.

Keywords: Cellular immunity; Cytokines; Cytomegalovirus; Lymphocytes; SARS-CoV-2; Th17.

MeSH terms

  • Adult
  • Antibodies, Viral
  • CD4-Positive T-Lymphocytes
  • CD8-Positive T-Lymphocytes
  • COVID-19*
  • Cytomegalovirus Infections*
  • Humans
  • Interleukin-17
  • Pandemics
  • SARS-CoV-2
  • Tumor Necrosis Factor-alpha

Substances

  • Tumor Necrosis Factor-alpha
  • Interleukin-17
  • Antibodies, Viral